https://www.streetinsider.com/PRNewswire/Harm+Reduction+Therapeutics+New+Drug+Application+for+RiVive%E2%84%A2+Over-the-Counter+Naloxone+Nasal+Spray+Accepted+and+Granted+Priority+Review+by+FDA/21005862.html
0
0
Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA - StreetInsider.com
12/26/22 at 4:26pm
Organization
StreetInsider.com
Authors
Details
51 words
Summarize
Drugs & Medications Health Sensitive Subjects New Drug Application Naloxone Nasal Spray FDA Granted Priority Review Pittsburgh
Low-cost, over-the-counter naloxone nasal spray advances to FDA review. Approval would increase access to this lifesaving medicine for the emergency treatment of opioid overdose. PITTSBURGH,...
Create an account or login to join the discussion